Proteins are an important class of biological macromolecules composed of amino acids present in living organisms. They play a variety of important roles, including participating in the metabolism, transportation, and transmission of nerve impulses in the body in organisms, and they are important molecules necessary to maintain life activities. Peptides are proteins of low molecular weight, usually consisting of less than 50 amino acid residues. Similar to proteins, peptides also play various important biological roles.
Ace Therapeutics offers hundreds of natural and recombinant proteins & peptides for stroke research, including but not limited to, cytokines, neuroprotective proteins, apoptotic factors, and inflammatory mediators.
Importantly, each of our products is verified by standard quality control procedures and tested for biological activity and low endotoxicity.
Please access our all-series proteins & peptides or contact our scientist for personalized assistance.
| Cat.# | Name | Size | Description | Price |
|---|---|---|---|---|
| ACPP-1196 | Insulin Receptor beta Blocking Peptide (AC1196) | 250 µg |
Insulin Receptor beta Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1197 | Dopamine Transporter Blocking Peptide (AC1197) | 250 µg |
Dopamine Transporter Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1198 | PDE6 Alpha Blocking Peptide (AC1198) | 250 µg |
PDE6 Alpha Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1199 | Beta crystallin S Blocking Peptide (AC1199) | 250 µg |
Beta crystallin S Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1200 | PAX8 Blocking Peptide (AC1200) | 250 µg |
PAX8 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1201 | HAND2 Blocking Peptide (AC1201) | 250 µg |
HAND2 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1202 | Pin1 Blocking Peptide (AC1202) | 250 µg |
Pin1 Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1203 | ADCY8 Blocking Peptide (AC1203) | 250 µg |
ADCY8 Blocking Peptide for Immmunodepletion, Competition Assay
|
inquiry |
| ACPP-1204 | P2Y1 Blocking Peptide (AC1204) | 250 µg |
P2Y1 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1205 | Human MECP2 Protein (AC1205) | 2 µg |
Methyl CpG Binding Protein 2 Human Recombinant
|
inquiry |
| ACPP-1206 | ELOVL4 Blocking Peptide (AC1206) | 250 µg |
ELOVL4 Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1207 | Dopamine Receptor D1 Blocking Peptide (AC1207) | 250 µg |
Dopamine Receptor D1 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1208 | beta Catenin Blocking Peptide (AC1208) | 250 µg |
beta Catenin Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1209 | CaMKII gamma Blocking Peptide (AC1209) | 250 µg |
CaMKII gamma Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1210 | Alpha SNAP Blocking Peptide (AC1210) | 250 µg |
Alpha SNAP Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.